Home / Author / Blaire Osborn, Ph.D.

Blaire Osborn, Ph.D.

Senior Director, Clinical Pharmacology and Translational Medicine, Integrated Drug Development

Blaire has over 25 years of drug development experience in the areas of clinical pharmacology and pharmacokinetics. Before joining Certara, she was a reviewer in the Office of Clinical Pharmacology, US Food and Drug Administration, in the Division of Cancer Pharmacology, CDER where, she participated in the assessment of multiple dose justification submissions under Project Optimus. Dr. Osborn is holds a Ph.D. in Pharmacology from The George Washington University.

Authored by Blaire Osborn, Ph.D.

Key Lessons from the 2nd Annual FDA ASCO WORKSHOP on Getting the Dosage Right: Optimizing Dosage Selection Strategies in Combination Cancer Therapies

Blog

The “Animal Rule” – What if a clinical trial simply isn’t ethical?

Blog